Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 184C (TMEM184C) is a membrane-associated protein encoded by the TMEM184C gene on chromosome 4. It is predicted to function in transmembrane transport and may act as a tumor suppressor influencing cell growth. Diseases associated with TMEM184C include mandibulofacial dysostosis with alopecia and hypoparathyroidism, X-linked. There is no current evidence that TMEM184C is a direct therapeutic target, nor are there drugs or specific biomarkers linked to this molecule[1][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 184C (TMEM184C).